<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04125264</url>
  </required_header>
  <id_info>
    <org_study_id>18/399-R_P</org_study_id>
    <nct_id>NCT04125264</nct_id>
  </id_info>
  <brief_title>Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis</brief_title>
  <acronym>ITU</acronym>
  <official_title>The Application of Intense Therapeutic Ultrasound in Plantar Fasciitis. A Randomized, Non-probabilistic and Superiority Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Complutense de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Complutense de Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It was previously hypothesized that patients receiving Intense Therapeutic Ultrasound (ITU)
      in addition to the standard of care would have a more rapid resolution of pain, faster return
      to activities, and a decrease in intra- and perifascial lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intense Therapeutic Ultrasound (ITU) is an established ultrasound-based therapy in which
      sound waves are concentrated and focused into a well-defined specific area of musculoskeletal
      tissue. Previous researches hipothesize that the application of ITU improve and accelerate
      healing in patients with chronic plantar fasciitis.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, Non-probabilistic and Superiority Controlled Clinical Trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Patient located in experimental group will be treated with ITU. Patient located in control group will be treated with the same protocoll of ITU without intensity.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain reduction</measure>
    <time_frame>24 weeks</time_frame>
    <description>Use of a Subjective Visual Analogue Scale (SVAS): the outmost left (0 cm) was labelled pain absence and the outmost right (10 cm) was labelled the maximum imagined pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plantar fasciia thickness reduction</measure>
    <time_frame>24 weeks</time_frame>
    <description>Longitudinal view of the plantar fasciia with the use of ultrasound probe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hypoechoic volume area reduction</measure>
    <time_frame>24 weeks</time_frame>
    <description>Longitudinal and transversal view of the hypoechoic area of plantar fasciia with the use of ultrasound probe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ankle range of motion reduction</measure>
    <time_frame>24 weeks</time_frame>
    <description>Goniometry of the ankle in the extended and flexed position of the knee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to incorporation to daily live activities</measure>
    <time_frame>24 weeks</time_frame>
    <description>Patients satisfaction scale (6 items)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomous gait without pain in the heel</measure>
    <time_frame>24 weeks</time_frame>
    <description>Patients autonomous gait scale (6 items)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of patients satisfaction</measure>
    <time_frame>24 weeks</time_frame>
    <description>Patients satisfaction scale (6 items)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Plantar Fasciitis</condition>
  <condition>Plantar Fasciitis, Chronic</condition>
  <condition>Ultrasound Therapy</condition>
  <arm_group>
    <arm_group_label>Intense therapeutic Ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the trial two applications of 1000 pulses each one (day one and day thirty) will be applied. Pulse regulation could be modified from 4 to 5 joules depending the presence or not of pain.
Conservative treatment of plantar fasciitis include: custom made foot orthosis with the same general characteristics plus plantar fasciia and achilles tendon stretching.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Non ITU application. Conservative treatment of plantar fasciitis include: custom made foot orthosis with the same general characteristics plus plantar fasciia and achilles tendon stretching.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intense Therapeutic Ultrasound</intervention_name>
    <description>Application of 1000 pulses, until 5000 joules (5 joules per pulse), during approximately 15 minutes, with the possibility of 5 minutes rest, depending on the tolerance of the patient.</description>
    <arm_group_label>Intense therapeutic Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both sex patients.

          -  Plantar fasciitis diagnosis: pain during walking during the first steps in the
             morning; pain due to palpation of plantar fasciia insertion.

          -  Chronic pain of at least 6 month.

          -  Longitudinal thickness of the plantar fasciia more than 4 millimeters.

          -  No previous surgery in the plantar fasciia.

          -  No previous application of alternative treatments such us shock waves or injections
             (last ninety days)

        Exclusion Criteria:

          -  Platelet count disorder or anticoagulation therapy.

          -  Anti-inflammatories usual treatment for the treatment of plantar fasciitis.

          -  Diabetic foot syndrome.

          -  Presence of metabolic disease such us: hypertension, hiper or hipothyroidism.

          -  Pregnancy or breastfeeding.

          -  Previous treatment with fluoroquinolones antibiotic.

          -  Bilateral plantar fasciitis.

          -  Diagnosed Autoimmune disesase.

          -  Morphofunctional disorders in the foot and ankle.

          -  Diagnosed fibromyalgia.

          -  Heel disestesy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>José Luis Lázaro Martínez, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Complutense Madrid</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raúl J. Molines Barroso, Phd</last_name>
    <phone>639059104</phone>
    <phone_ext>+34</phone_ext>
    <email>rauljmolines@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diabetic foot Unit Complutense University</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Raúl Juan Molines Barroso, Phd</last_name>
      <phone>639059104</phone>
      <phone_ext>+34</phone_ext>
      <email>rauljmolines@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>José Luis Lázaro Martínez, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ángel Manuel Orejana García, Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pedro Villalta García, Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta López Herranz, Phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 10, 2019</study_first_submitted>
  <study_first_submitted_qc>October 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2019</study_first_posted>
  <last_update_submitted>October 14, 2019</last_update_submitted>
  <last_update_submitted_qc>October 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Complutense de Madrid</investigator_affiliation>
    <investigator_full_name>Raúl Juan Molines Barroso, Phd</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

